[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bio-pharmaceuticals Logistics Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 – 2020f

April 2016 | 60 pages | ID: BFD20767B30EN
Aniruddha Sowale

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Temperature control, regulatory compliance, security, safety and chain of custody are the key obstacles that can stop the bio-pharmaceutical manufacturers at every turn. As a remedy, the strategic supply chain management will help the manufacturers to overcome these obstacles. Logistics is the key integral part of supply chain management, which deals with procurement, planning and implementation of all the logistics activities in an organization. The effective logistics management will help the pharmaceutical companies to have a constant supply of drugs, devices and equipment from various dealers and distributors in different locations.

The global pharmaceutical market has more than doubled in the past ten years and is expected to reach USD 942 billion in terms of sales volume by the end of 2016. Moreover, patent rights for several leading drugs are set to expire, indicates that large portion of sales will shift from original brand manufacturer to generic manufacturers. Similar to other sectors, the pharmaceutical industry is also undergoing the geographic shift in its production facilities and sales markets. Markets like Asia, Latin America, Middle East, China, etc. are becoming increasingly attractive for these pharmaceutical companies, however, these markets are considered as most challenging in terms of supply chain regulations.

At present, the distribution structure in the European and American markets are heavily inclined towards national warehouses both regionally and centrally. Developing warehouse structures and outsourcing to logistics service providers are the key focus areas for the pharmaceutical manufacturers. Low cost and greater visibility in supply chain are the main advantages of outsourcing logistics services and is becoming an integral part of overall business strategy.

The primary driving factor for the growth of this market include strict regulations in the form of Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP), which summarize the criteria relating to the purchase, storage and export of medicines. In addition, factors like increasing demand for temperature sensitive pharmaceutical products, new delivery methods and growing demand for logistics outsourcing services could contribute to the growth of this market.

Along with these driving factors, there are also certain restraining factors that could hinder the growth of this market, which includes issues related to confidentiality of the proprietary information, loss of control and deteriorating services.

Geographically, Asia-Pacific dominates the market, which is evident from the presence of key players, low logistics costs and also increasing trend in logistics outsourcing services.

Panalpina, DHL, FedEx and UPS are amongst the leading logistic service providers in the industry.
1 SCOPE OF THE REPORT

  1.1.1 Report description
  1.1.2 Research methodology
  1.1.3 List of abbreviations
  1.1.4 Market segmentation
1.2 Executive summary
1.3 Qualitative analysis
  1.3.1 Market overview
    1.3.1.1 Drivers
    1.3.1.2 Restraints
    1.3.1.3 Opportunities
  1.3.1 Porters five forces analysis
  1.3.2 Value chain analysis
  1.3.3 Competitive matrix of the key companies
1.4 Global Bio-pharmaceutical logistics market, by type of transport, 2012 – 2020f
  1.4.1 Cold-chain transport
  1.4.2 Non cold-chain transport
1.5 Global Bio-pharmaceutical market, by product type, 2012 – 2020f
  1.5.1 Generic drugs
  1.5.2 Branded drugs
1.6 Global Bio-pharmaceutical Market, by Geography, 2012 – 2020f
  1.6.1 North America
  1.6.2 Europe
  1.6.3 APAC
  1.6.4 Rest of the World
1.7 Company Profiles
  1.7.1 FedEx
  1.7.2 DHL
  1.7.3 Panalpina
  1.7.4 UPS


More Publications